Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Tech 5: Trump to Prioritize Crypto, Biden Blocks AI Chip Exports January 19, 2025 Noble Minerals Acquires a Property with Significant Uranium, Rare Earth, Phosphorus and Silver Mineralization in Northern Quebec January 18, 2025 Bold Ventures Showcases New Gold Discovery and Recent New Results at Vancouver Resource Conferences January 18, 2025
Noble Minerals Acquires a Property with Significant Uranium, Rare Earth, Phosphorus and Silver Mineralization in Northern Quebec January 18, 2025
Bold Ventures Showcases New Gold Discovery and Recent New Results at Vancouver Resource Conferences January 18, 2025